Emerging at the UK, retatrutide, a novel molecule, is creating considerable buzz within the healthcare community regarding its ability for body management . This dual GIP and GLP-1 agent agonist seems to provide a considerable benefit over current therapies, showing encouraging results in initial clinical assessments. Researchers suggest its partic